CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 8-K Event Shareholder vote results
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · Other events
- 4 Planned sale PRINCIPAL ACCOUNTING OFFICER sold 4,000 shares at an average $22.50 ($90,000)
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 2,000 shares at $25.00 ($50,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,327 shares at $14.60 ($19,374)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,498 shares at $14.60 ($51,071)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Bylaws or fiscal year change
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 2,708 shares at $14.82 ($40,133)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,028 shares at $14.82 ($15,235)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 1,095 shares at $17.05 ($18,670)
Page 5 of 70 · 1,382 filings